Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

NCT03038113

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Linear Clinical Research Limited Nedlands, Western Australia, Australia
  • Queen Mary Hospital Hong Kong
  • Prince of Wales Hospital Shatin, New Territories, Hong Kong
View all 19 locations
View Trial Details
Completed

Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B

NCT00907894

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigator Site Frankfurt, Germany
  • Novartis Investigator Site Starnberg, Germany
  • Novartis Investigator Site Wuppertal, Germany
View Trial Details
Completed

Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants

NCT02166047

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Los Angeles, California, United States
  • San Diego, California, United States
  • San Francisco, California, United States
  • San Jose, California, United States
View all 23 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects

NCT03020745

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Beijing, China
View all 21 locations
View Trial Details

Related conditions